Items where Author is "Vokinger, Kerstin N."

Jenei, Kristina, Glaus, Camille E.G. and Vokinger, Kerstin N. (2024) WHO shapes priorities for medicines? An analysis of the applicants and decision makers within the historical evolution of the WHO Model Lists of Essential Medicines. The Lancet, 404 (10460). pp. 1365-1374. ISSN 0140-6736

Jenei, Kristina, Lythgoe, Mark P. and Vokinger, Kerstin N. (2024) Shortages of essential cancer medicines: who is responsible and what are the possible solutions? The Lancet Oncology, 25 (1). 23 - 26. ISSN 1470-2045

Vokinger, Kerstin N., Perényi, Gellért and Wouters, Olivier J. ORCID: 0000-0002-2514-476X (2023) Investments in research and development for supplemental drug indications: implications for drug price negotiations. JAMA Health Forum, 4 (9). E232798. ISSN 2689-0186

Vokinger, Kerstin N. and Naci, Huseyin ORCID: 0000-0002-7192-5751 (2022) Negotiating drug prices in the US - lessons from Europe. JAMA Health Forum, 3 (12). ISSN 2689-0186

Carl, David L., Laube, Yannic, Serra-Burriel, Miquel, Naci, Huseyin ORCID: 0000-0002-7192-5751, Ludwig, Wolf Dieter and Vokinger, Kerstin N. (2022) Comparison of uptake and prices of biosimilars in the US, Germany, and Switzerland. JAMA network open, 5 (12). ISSN 2574-3805

Vokinger, Kerstin N., Hwang, Thomas J., Carl, David L., Laube, Yannic, Ludwig, Wolf Dieter, Naci, Huseyin ORCID: 0000-0002-7192-5751 and Kesselheim, Aaron S. (2022) Price changes and within-class competition of cancer drugs in the USA and Europe: a comparative analysis. The Lancet Oncology, 23 (4). 514 - 520. ISSN 1470-2045